These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 960680)
1. Can a national all voluntary blood transfusion service by adequate blood component therapy cover actual and future needs of AHF? Vox Sang; 1976 Oct; 31(4):296-320. PubMed ID: 960680 [No Abstract] [Full Text] [Related]
2. Can a national all voluntary blood transfusion service by adequate blood component therapy cover actual and future needs of albumin? Barker LF; Cazal P; Haussman HG; Hollán S; Kellner A; Lundsgaard-Hansen P; Schiff P Vox Sang; 1976; 31?-73(3):225-38. PubMed ID: 969394 [No Abstract] [Full Text] [Related]
4. AIDS: a problem for the transfusion service? Barbara JA; Contreras M; Hewitt P Br J Hosp Med; 1986 Sep; 36(3):178-84. PubMed ID: 3094615 [TBL] [Abstract][Full Text] [Related]
5. A method for the production of AHG rich cryoprecipitates & their use in the management of bleeding episodes in haemophilia. Kwa SB; Chen YF Singapore Med J; 1968 Mar; 9(1):12-6. PubMed ID: 5659889 [No Abstract] [Full Text] [Related]
6. The safe blood components for a hemophilia patient: a case report. Chuansumrit A; Pandhawong S; Tardtong P; Isarangkura P Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():198-200. PubMed ID: 7886573 [TBL] [Abstract][Full Text] [Related]
7. The physiologic basis for therapy of classic hemophilia (factor 8 deficiency) and related disorders. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med; 1967 Oct; 67(4):856-82. PubMed ID: 5299081 [No Abstract] [Full Text] [Related]
8. Therapy for AHF and PTC hemophilia. I. Seeler RA IMJ Ill Med J; 1970 May; 137(5):518-21. PubMed ID: 4392774 [No Abstract] [Full Text] [Related]
9. [Safe and cost-conscious supply of factor-VIII-deficient Swiss hemophiliacs with AHF preparations]. Stampfli K Ther Umsch; 1977 Oct; 34(10):717-24. PubMed ID: 918896 [No Abstract] [Full Text] [Related]
10. Specific therapy in hemophilia. Hutaff LW N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809 [No Abstract] [Full Text] [Related]
11. [Hepatitis in hemophilia]. Eggeling B; Sennekamp J; Brackmann HH; Werner I Schweiz Med Wochenschr; 1974 Sep; 104(36):1250-5. PubMed ID: 4445853 [No Abstract] [Full Text] [Related]
12. Prophylactic therapy in classical hemophilia: a preliminary report. Robinson PM; Tittley P; Smiley RK Can Med Assoc J; 1967 Sep; 97(11):559-61. PubMed ID: 6050888 [No Abstract] [Full Text] [Related]
13. Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors. Ehrenforth S; Kreuz W; Funk M; Auerswald G; Scharrer I Thromb Haemost; 1994 Nov; 72(5):784-5. PubMed ID: 7900088 [No Abstract] [Full Text] [Related]